# Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma

> **NCT07477912** · PHASE1,PHASE2 · RECRUITING · sponsor: **Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Myeloma Refractory

## Interventions

- **BIOLOGICAL:** anti BCMA CAR-T cells

## Key facts

- **NCT ID:** NCT07477912
- **Lead sponsor:** Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07477912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07477912, "Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07477912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*